As shown in Figure 3, the treatment with Tarceva or NuF could inhibit tumor IL-6 protein expression, whereas the NuF treatment could inhibit the PTHrP expression at both the protein and gene levels (Figure 3A,B). The gene discussed is IL6; the disease is neoplasm.